SHINPOONG PHARMACEUTICAL CO.,LTD

019170 KRX Pharmaceuticals Pharmaceuticals
KOSPI
₩10,020.00
+1.73%
Delayed · cached 15 min
Fair Value Analysis →

Price Chart

Price50-day avg200-day avg

How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.

Strengths

  • Low debt: debt-to-equity of 0.3.
  • Current assets comfortably cover current liabilities (current ratio 3.09).

!Watch-points

  • Return on equity is on the lower side at 3.3%.
  • Return on capital employed is on the lower side at 5%.
  • Net profit margin is slim at 3.6%.
  • Sales growth has been slow over five years (about 2% a year).

These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.

Forensic Checks

Altman Z-ScoreDistress zone
1.48

In Altman’s study, scores in this range were associated with a higher incidence of financial distress.

Computed without the market-value term.

Piotroski F-ScoreModerate
5 / 5

The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.

Based on 5 of the 9 signals — the rest need data not available for this stock.

These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.

Key Ratios

Market Cap₩5,181억
Current Price₩ 10,020.00
High / Low₩ 15,900.00 / 6,310.00
Stock P/E58.26
Book Value₩ 5,479.39
ROCE4.99%
ROE3.27%
Debt to Equity0.30
Current Ratio3.09
EPS₩ 172.00
PAT Margin3.57%
ICR1.56
Compounded Sales Growth
10 Years
5 Years 2.13%
3 Years
TTM
Compounded Profit Growth
10 Years
5 Years
3 Years
TTM
Stock Price CAGR
10 Years
5 Years
3 Years
1 Year
Return on Equity
10 Years
5 Years
3 Years
Last Year 3.27%
Educational data only. Not a recommendation to buy, sell or hold any security.